Timing of First-Time Use of Biologics and Healthcare Costs and Utilization in Psoriasis

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.03.1723
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

276 U.S. Regional Differences in Psoriasis Care: Healthcare Utilization, Costs, and Access to Biologics

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Healthcare Resource Utilization and Associated Costs in Patients With Advanced Melanoma Receiving First-Line Ipilimumab

Journal of Cancer Therapy
2015English

267 Regional Disparities in Healthcare Utilization and Costs of Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Functional Status, Healthcare Utilization, and the Costs of Liver Transplantation

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2017English

Biologics in the Management of Psoriasis

Clinical, Cosmetic and Investigational Dermatology
Dermatology
2009English

Resource Use in Patients With Psoriasis After the Introduction of Biologics in Sweden

Acta Dermato-Venereologica
DermatologyMedicine
2015English

National U.S. Time-Trends in Opioid Use Disorder Hospitalizations and Associated Healthcare Utilization and Mortality

PLoS ONE
Multidisciplinary
2020English

Time-To-Initiation, Healthcare Utilization, and Costs of Treatment of Attention Deficit Hyperactivity Disorder Among Texas Medicaid Preschoolers

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Psoriasis, Cardiovascular Events, and Biologics: Lights and Shadows

Frontiers in Immunology
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy